Initial experience of laparoendoscopic single-site radical prostatectomy with a novel purpose-built robotic system

作     者：Zheng Wang Chao Zhang Chengwu Xiao Yang Wang Yu Fang Baohua Zhu Shouyan Tang Xiaofeng Wu Hong Xu Yi Zhou Lingfen Wu Zhenjie Wu Bo Yang Yi He Yi Liu Linhui Wang Zheng Wang;Chao Zhang;Chengwu Xiao;Yang Wang;Yu Fang;Baohua Zhu;Shouyan Tang;Xiaofeng Wu;Hong Xu;Yi Zhou;Lingfen Wu;Zhenjie Wu;Bo Yang;Yi He;Yi Liu;Linhui Wang

作者机构：Department of UrologyChanghai HospitalNaval Medical UniversityShanghaiChina Department of AnesthesiologyChanghai HospitalNaval Medical UniversityShanghaiChina Department of UrologyThe Affiliated Hospital of Jiaxing UniversityZhejiangChina 

出 版 物：《Asian Journal of Urology》 (亚洲泌尿外科杂志（英文）)

年 卷 期：2023年第10卷第4期

页      面：467-474页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：The authors would like to express their gratitude to Prof.Kai Xu and his research and development team from Shanghai Jiao Tong University,Shanghai,China,for their invaluable technical support of this study.This research was funded by the National Key Research and Development Program of China(Grant No.2022YFB4700904 to Wang L) Research-Oriented Physicians'Innovative Transformation Training Program of Development Center,Shanghai Shenkang Hospital,Shanghai,China(Grant No.SHDC2022CRS010B to Tang S) 

主　　题：Laparoendoscopic single-site surgery Robotic surgical procedure Prostatectomy Prostatic cancer 

摘      要：Objective This prospective single-arm clinical trial aimed to evaluated the feasibility and safety of the application of the SHURUI system(Beijing Surgerii Technology Co.,Ltd.,Beijing,China),a novel purpose-built robotic system,in single-port robotic radical *** Sixteen patients diagnosed with prostate cancer were prospectively enrolled in and underwent robotic radical prostatectomy from October 2021 to August 2022 by the SHURUI single-port robotic surgical *** demographic and baseline data,surgical,oncological,and functional outcomes as well as follow-up data were *** The mean operative time was 226.3(standard deviation[SD]52.0)min,and the mean console time was 183.4(SD 48.3)min,with the mean estimated blood loss of 116.3(SD 90.0)*** mean length of postoperative hospital stay was 4.50(SD 0.97)*** patients had postoperative complications(Clavien-Dindo Grade II),and both patients improved after conservative *** patients’postoperative prostate-specific antigen levels decreased to below 0.2 ng/mL 1 month after *** mean prostate-specific antigen level further decreased to a mean of 0.0219(SD 0.0641)ng/mL 6 months after *** days postoperatively,12 out of 16 patients reported using no more than one urinary pad per day,and all patients reported satisfactory urinary control without the need for pads 6 months after *** The SHURUI system is safe and feasible in performing radical prostatectomy via both transperitoneal and extraperitoneal *** control and urinary continence were satisfying for patients enrolled *** next phase involves conducting a large-scale,multicenter randomized controlled trial to thoroughly assess the effectiveness and safety of the new technology in a broader population.